Weekly signal · MRVL · Technology

Marvell Technology Group Ltd (MRVL) rebound meets a still-negative one-month tape

The semiconductor stock’s weekly setup is active, but pressure readings and lighter turnover keep confirmation mixed.

Marvell Technology Group Ltd
Latest218.72 USD
1W move16.6%
Volume0.5x
TrendActive
Weekly stock chart context for Marvell Technology Group Ltd in semiconductors.

Market update

What happened

Marvell Technology Group Ltd (MRVL) closed at 218.72 USD for the week ended Aug. 7, with a 16.6% one-week return on the weekly price path over 52 weeks.

The evidence is mixed: the four-week return is still -7.2%, while the twelve-week return is 23.6%. Market Dynamics at -0.52 shows pressure, even as Relative Strength sits at 56.9.

Continue your research

Explore MRVL across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

MRVL coverage

Evidence context